Supreme Plc Regulatory News (SUP)

10 March 2021

Supreme plc

("Supreme" or the "Company" or the "Group")

Company Share Option Plan 2021, Unapproved Share Option Scheme 2021

&

Grant of Awards to Directors

Supreme plc (AIM: SUP), a leading manufacturer, supplier and brand owner of fast-moving consumer products announces the launch of its Company Share Option Plan ("CSOP") and its Unapproved Share Option Scheme for 2021 and the grant of options to Directors.

Company Share Option Plan 2021 ("CSOP") and Unapproved Share Option Scheme 2021 ("Unapproved Scheme")

Under the tax-advantaged CSOP a limited number of eligible employees have been granted options to subscribe for ordinary shares in the Company of 10p each ("Shares"), with an exercise price of 174 pence per Share equal to the closing middle market price on 15 February 2021. The options were granted on 16 February 2021 and will be exercisable by the holder at any time between the third and tenth anniversaries of the date of the grant. Upon exercise, the relevant Shares will be allotted and further announcements will be made regarding this in due course. Some of those employees have been granted additional options on the same basis under the Unapproved Scheme to the extent that the total number of options granted to them exceeded the maximum number permitted to be granted under the CSOP by HMRC rules.

23 employees have been granted options under the CSOP over a total of 206,886 Shares and 4 employees have been granted options under the Unapproved Scheme over a total of 94,825 Shares, being in aggregate 301,711 Shares representing in total 0.26% of the Company's issued share capital.

Grant of options to Directors

As outlined in the Company's Admission Document, dated 27 January 2021, the Company has now made the following grants to Sandy Chadha and Suzanne Smith ("Director Options"). These were made yesterday under the Unapproved Scheme.

Options to subscribe for a total of 5,825,000 Shares at nominal value were granted to Sandy Chadha in two equal tranches each equating to 2.5 per cent. of the issued share capital of the Company as at the date of admission on 1 February 2021 ("Admission"). Each tranche of options will be subject to a performance condition which must be wholly satisfied for the relevant option to be exercisable. The performance condition for the first tranche of options is that total shareholder return per Share ("TSR") from Admission until the third anniversary of Admission is at least 100 per cent. of the placing price of 134 pence as at Admission (the "Placing Price"). The performance condition for the second tranche of options is that the TSR from Admission until the fifth anniversary of Admission is at least 200 per cent. of the Placing Price.

Options to subscribe for up to 111,940 Shares at nominal value were granted to Suzanne Smith. The options are subject to a performance condition requiring an average annual TSR of 7.5 per cent. to become exercisable in part and an annual average TSR of 10 per cent. to become fully exercisable, in each case measured over a period of 3 years from Admission as against the Placing Price.

Following the CSOP, Unapproved Scheme awards and the Director Options, the Company will have options outstanding over 6,238,651 shares, representing 5.36% of the Company's issued share capital (plus a further 1,667,722 for options granted prior to Admission representing a further 1.43% of the Company's issued share capital).

Further options or share awards made at the discretion of the Company following the date of this announcement are (together with the CSOP, the Unapproved Scheme awards and the Director Options in this announcement but excluding options issued prior to Admission) subject to a cap not exceeding 10 per cent. of the issued share capital of the Company.

Contacts